Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How EvoLV Stands Out Among Top Life Sciences Consultancies in the USA

Apr 19, 2025

Innovative Approaches in Life Sciences Consulting

In a rapidly evolving industry like life sciences, staying ahead requires more than just expertise; it demands innovation, adaptability, and a deep understanding of emerging trends. EvoLV distinguishes itself as a leader among top life sciences consultancies in the USA by leveraging these qualities to deliver exceptional results. By embracing cutting-edge technologies and methodologies, EvoLV consistently provides its clients with tailored solutions that address their unique challenges.

EvoLV's commitment to innovation is evident in its strategic use of data analytics and artificial intelligence (AI) to optimize processes and outcomes. These tools not only enhance decision-making but also allow for the identification of new opportunities in research and development. As a result, clients can benefit from more efficient operations and accelerated time-to-market for their products.

innovation lab

Client-Centric Approach

What sets EvoLV apart is its unwavering focus on client satisfaction. The consultancy prioritizes building long-term relationships with its clients by understanding their specific needs and goals. This client-centric approach ensures that the solutions provided are not only effective but also sustainable in the long run. By maintaining open lines of communication and fostering collaboration, EvoLV helps clients navigate the complexities of the life sciences industry with confidence.

Moreover, EvoLV's team of seasoned professionals brings a wealth of experience from various sectors within the life sciences field. This diverse expertise enables the consultancy to offer comprehensive services across multiple domains, including pharmaceuticals, biotechnology, and medical devices. Clients benefit from a holistic perspective that considers all aspects of their business operations.

team collaboration

Commitment to Quality and Compliance

In the highly regulated world of life sciences, maintaining quality and compliance is paramount. EvoLV understands the critical importance of adhering to regulatory standards and works diligently to ensure that all projects meet the necessary requirements. The consultancy's robust quality management systems are designed to minimize risks and safeguard client interests at every stage of the project lifecycle.

EvoLV's proactive approach to regulatory compliance not only protects clients from potential pitfalls but also enhances their reputation in the industry. By consistently delivering high-quality results, EvoLV has earned the trust of its clients and established itself as a reliable partner in their success.

compliance checklist

Driving Innovation Through Collaboration

Collaboration is at the heart of EvoLV’s philosophy. The consultancy believes that the best solutions emerge from the synergy between diverse perspectives and expertise. EvoLV actively fosters partnerships with academic institutions, research organizations, and other industry stakeholders to drive innovation and advance knowledge in the life sciences sector.

These collaborative efforts have led to groundbreaking discoveries and advancements that benefit not only EvoLV's clients but also the broader scientific community. By staying at the forefront of research and development, EvoLV continues to shape the future of life sciences consulting.

Conclusion

EvoLV’s unique combination of innovation, client-focused service, commitment to quality, and collaborative spirit sets it apart as a leader among top life sciences consultancies in the USA. By continuously pushing the boundaries of what is possible, EvoLV not only meets the current needs of its clients but also anticipates future challenges and opportunities. As the life sciences industry continues to evolve, EvoLV remains dedicated to empowering its clients with the insights and strategies needed to thrive in an ever-changing landscape.